Loading
Life sciences · Journal article
Frontiers in Bioengineering and Biotechnology · September 14, 2026
No summary has been generated for this record yet. What follows is drawn from its source metadata only.
Journal article.
No findings were extractable from the material analysed.
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
The source did not state who this applies to in practice.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
This record has not been graded across any dimension yet. Treat the label above as provisional and read the source.
What is missing. This record has no bottom line, key findings, reported figures, evidence dimensions. That is a gap in the analysis, not a judgement about the study.
Background Balancing photothermal performance and drug-delivery capacity remains a key challenge in the structural design of multifunctional nanomedicines. Hollowing can increase internal space for drug accommodation but may simultaneously reduce the amount of NIR-absorbing Prussian blue (PB), creating an inherent trade-off between drug-delivery capacity and photothermal performance. Methods The hollow state of hollow mesoporous Prussian blue (HMPB) nanocubes was regulated by controlled HCl etching, followed by a common mesoporous silica (mSiO 2 ) coating, to generate low-, intermediate-, and high-hollow formulations. The resulting formulations were evaluated for physicochemical properties, photothermal performance, doxorubicin (DOX) loading and release, cellular response, intracellular fluorescence, chemo-photothermal interaction, and preliminary microfluidic perfusion performance. Results Increasing hollowing enhanced DOX loading from 525 to 867 μg⋅mg −1 and promoted drug release, but progressively reduced photothermal performance. The measured photothermal conversion efficiencies of 1-, 2-, and 3-HMPB@mSiO 2 were 23.37%, 18.62%, and 14.41%, respectively. ICP-MS showed decreasing Fe contents with increasing hollowing, while PB-equivalent-mass-matched measurements yielded similar photothermal conversion efficiencies (16.80%, 15.80%, and 14.41%), indicating that PB abundance is a major contributor to the observed photothermal differences. DOX release was enhanced by both mild acidity and mild hyperthermia relative to pH 7.4/37 °C. After treatment-matched correction for nanoparticle-related optical interference, the blank carriers showed limited acute carrier-associated cytotoxicity in HeLa cells over 24 h, and quantitative fluorescence imaging confirmed effective intracellular DOX delivery. At an equal total formulation concentration, the intermediate-hollow 2-HMPB@mSiO 2 -DOX formulation produced the strongest combined therapeutic response. Multi-dose combination-index, Bliss-independence, and Loewe-additivity analyses further supported increasingly synergistic chemo-photothermal interactions with increasing treatment effect. Preliminary syringe-pump-driven microfluidic perfusion in physiological medium preserved the principal structure-dependent trends in particle dispersion, drug leakage, and NIR heating. Conclusion These results demonstrate that hollow-state engineering provides a practical strategy for balancing competing photothermal and drug-delivery functions in PB-based nanoplatforms.